MCL1 and hepatocellular carcinoma: Moreover, we confirmed that high DHHC7 could be induced in c-Myc/MCL1-treated mice liver compared to health control (Fig. 6H), suggesting that DHHC7 is involved in the malignancy of hepatic carcinoma cells and MY-D-4 is a promising inhibitor for HCC treatment.